Podcast

MPR Weekly Dose Podcast: Episode 15

Back from our Thanksgiving break, this week we talk about the new approval for sickle cell disease; the re-introduction of a product that was taken off the market in the 60’s; The first ready-to-use phenylephrine injection; A new ultrasound enhancing agent; And an approval for arthritis.

MPR Weekly Dose Podcast: Episode 14

This week on the Pod we talk about the FDA Advisory Committee vote on Vascepa; Antibiotic resistant threats; New contact lenses approved to slow myopia in children; A new treatment for sickle cell disease; And an approval for the rare disease, acute hepatic porphyria.

MPR Weekly Dose Podcast: Episode 13

This week on the Weekly Dose we talk about the first lung transplant due to vaping-related illness; A new approval for patients with beta thalassemia; Opioids in osteoarthritis; A new, free test to help diagnose COPD; and news of a potential new therapy for hypercholesterolemia.

MPR Weekly Dose Podcast: Episode 12

This week we talk about the possible NDMA in ranitidine products; Approval of a new flu vaccine; The return of an antiarrhythmic agent; A new treatment for H. pylori infection; and the risk of biotin interference in test results that could lead to missed diagnoses.

MPR Weekly Dose Podcast: Episode 10

This week we talk about the resurrection of Biogen’s novel Alzheimer treatment; A “landmark” approval in cystic fibrosis; Expanded indication for Farxiga; The first topical minocycline formulation for acne vulgaris; and the Johnson & Johnson baby powder recall.

MPR Weekly Dose Podcast: Episode 9

This week we talk about new treatment approvals for acute migraine, dry eye disease and schizophrenia; a new indication for Xarelto; and the CDC issue an interim guidance for physicians regarding electronic cigarette, or vaping, product use-associated lung injury, or ‘EVALI’.

MPR Weekly Dose Podcast: Episode 6

This week: A new type 2 diabetes treatment in tablet form; Pancreatitis treatment gains Orphan Drug status; New approval for smallpox, monkeypox; An investigational treatment for Guillain-Barré Syndrome; and big changes at e-cigarette maker, Juul.